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Summary 
Eotaxin is a member of the C-C family of chemokines and is released during antigen challenge 
in a guinea pig model of allergic airway inflammation (asthma).  Consistent with its putative 
role in eosinophilic inflammation, eotaxin induces the selective infiltration  of eosinophils when 
injected into the lung and skin. Using a guinea pig lung cDNA library, we have cloned full- 
length eotaxin cDNA. The cDNA encodes a protein of 96 amino acids, including a putative 
23-amino acid hydrophobic leader sequence, followed by 73 amino acids composing the mature 
active eotaxin protein. The protein-coding region of this cDNA is 73, 71, 50, and 48% identical 
in nucleic acid sequence to those of human macrophage chemoattractant protein (MCP) 3, MCP-1, 
macrophage inflammatory protein (MIP) lot, and RANTES, respectively. Analysis of genomic 
DNA suggested that there is a single eotaxin gene in guinea pig which is apparently conserved 
in mice. High constitutive levels of eotaxin mRNA expression were observed in the lung, while 
the intestines,  stomach,  spleen, liver, heart,  thymus, testes, and kidney expressed lower levels. 
To determine if eotaxin mRNA levels are elevated during aUergen-induced eosinophilic airway 
inflammation, ovalbumin  (OVA)-sensitized guinea pigs were challenged with aerosolized an- 
tigen. Compared with the lungs from saline-challenged animals, eotaxin mRNA levels increased 
sixfold within 3 h and returned to baseline by 6 h. Thus, eotaxin mRNA levels are increased 
in response to allergen challenge during the late phase response. The identification of constitutive 
eotaxin  mRNA expression in multiple tissues suggests that in addition to regulating airway 
eosinophilia, eotaxin is likely to be involved in eosinophil recruitment into other tissues as well 
as in baseline tissue homing. 
E 
osinophils are circulating leukocytes that are thought to 
dwell predominantly in tissues where they are believed 
to survive for at least 2 wk (1, 2). Here they can mediate 
pro-inflammatory changes by the release of preformed toxic 
cationic proteins and by the de novo synthesis of oxygen rad- 
icals and lipid mediators (3, 4). The mechanisms that regu- 
late baseline eosinophil tissue homing and tissue recruitment 
in selected  diseases (e.g., asthma, parasitic infections, and malig- 
nancy) are areas of active investigation  (5). Eosinophils ex- 
press several adhesion molecules (e.g., fll and f12 integrins) 
that participate in their interaction with the endothelium. 
Furthermore, various chemoattractants active on eosinophils, 
including leukotriene B4, platelet activating factor, and sev- 
eral chemokines (e.g., macrophage chemoattractant protein 
[MCP]-3,  RANTES,  macrophage  inflammatory  protein 
[MIP]-lot, and IL-8), have been identified as mediators of eo- 
sinophil  trafficking  (5-10).  In  addition,  IL-5,  a cytokine 
released by Th2 lymphocytes, specifically  regulates eosinophil 
growth and differentiation  (11). However, while IL-5 over- 
production in transgenic mice causes a marked rise in blood 
eosinophilia, it does not result in eosinophil tissue accumu- 
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lation and organ damage (12). None of these molecules are 
eosinophil specific and their relative importance in selected 
diseases and in experimental animal models of allergy remains 
unclear. 
Allergic airway inflammation in the guinea pig provides 
a model for examining eosinophil accumulation in tissues and 
thus provides a system by which to assess the effectors of eo- 
sinophilic inflammation (13-15). As in patients with allergic 
asthma, exposure of sensitized guinea pigs to aerosolized an- 
tigen results in an immediate airway hypersensitivity charac- 
terized by mast cell degranulation.  This is followed by a late 
phase of hypersensitivity that is associated with the accumu- 
lation of large numbers of eosinophils in the airways. Using 
an in vivo bioassay to measure eosinophil  infiltration  into 
guinea pig skin, a novel C-C chemokine, eotaxin,  has been 
recently purified (16, 17). Eotaxin appears to be unique among 
the chemokines since it causes the selective infiltration of eo- 
sinophils into the lungs and skin of animals. To further study 
the role of this molecule in inflammation and in experimental 
models of airway hypersensitivity, we have cloned the full- 
length guinea pig eotaxin cDNA and studied the expression 
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challenged  state. 
Materials and Methods 
Animals.  Airway inflammation was induced in male Hartley 
guinea pigs (300-500 g body weight) by OVA sensitization as pre- 
viously reported  (18). Briefly, guinea pigs were pretreated  with 
pyrilamine malate by i.p. injection before aerosolized OVA (1% 
wt/vol in 0.9% sterile sodium chloride) or saline alone. Animals 
were exposed in an aerosol chamber on three occasions at 7-d in- 
tervals and the lungs were harvested at various points after the final 
exposure. Organs were frozen in liquid nitrogen and used for sub- 
sequent RNA isolation. A guinea pig lung epithelial cell line (JH4 
clone 1) and a guinea pig colon adenocarcinoma cell line (GPC-16) 
were purchased from American Type Tissue Culture Collection 
(Rockville, MD). 
Eotaxin Cloning.  Based  on the published amino acid sequence 
of guinea pig eotaxin (17), the following degenerate oligonucleotide 
primers containing EcoR1 and BamH1 restriction sites, respectively, 
were synthesized: CCGGAATI~CA(CT)CC(AGCT)GG(AGCT)- 
AT(ACT) (128-fold degeneracy) and CGCGGATCCGC(AG)CA- 
(AGT)ATCAT(CT)TT(AG)TC  (32-fold degeneracy). First strand 
cDNA was synthesized from guinea pig lung RNA and PCR was 
performed with an initial five cycles at 37~  for 60 s, followed 
by 25 cycles at 500C for 60 s (denaturation  at 95~  for 30 s and 
extension at 72~  for 90 s) to amplify a 130-bp eotaxin cDNA 
fragment that  was subsequently subcloned into Bluescript II KS 
(Stratagene Inc., La Jolla, CA). Construction of a cDNA library 
using poly(A) § RNA isolated from the lung of an OVA-sensitized 
guinea pig was performed using Stratagene ZAP Express Vector 
according to the directions of the manufacturer. 500,000 indepen- 
dent clones were subsequently amplified and an aliquot of this cDNA 
library containing 106 phage was screened with the 130-bp eotaxin 
cDNA that had been 32p-labeled  with Klenow enzyme. Two phage- 
raids were isolated and subsequently subjected to automated  se- 
quencing  on both  strands  using  instrumentation  (model 373a; 
Applied Biosystems Inc., Foster City, CA) and the dye-terminator 
protocol. Sequence analysis was performed using software developed 
by the University  of Wisconsin  genetics computer  group (19). 
DNA andRNA Analysis.  RNA was isolated by CsC1 centrifu- 
gation in guanidine isothiocyanate (20). DNA was isolated from 
these gradients as well. In some cases, RNA was isolated using 
RNAzol (Biotecx Lab, Inc., Houston, TX) according to the direc- 
tions of the manufacturer.  Poly(A) + RNA was enriched by elu- 
tion  through  an  oligo  dT  column  (Pharmacia  LKB Nuclear, 
Gaithersburg,  MD). 10 mcg of total RNA, 2 mcg of poly(A) § 
ILNA, or 10 mcg of restriction endonuclease cut DNA was elec- 
trophoresed in agarose and transferred to Gene Screen (Dupont- 
New England Nuclear, Boston, MA) membranes. Membranes were 
hybridized with 32p-labeled full-length  cDNA or a fragment  en- 
coding the translated protein (bp 57-356). High-stringency hybrid- 
ization was performed in 50% formamide, 10% dextran  sulfate, 
5 x SSC, lx  Denhardt's solution (0.0002% [wt/vol] polyvinylpyr- 
rolidone, 0.0002%  [wt/vol]  BSA, 0.0002%  [wt/vol] Ficoll 400), 
1% (wt/vol) SDS, 100 mcg/ml denatured herring  sperm DNA, 
and 20 mM Tris at 42~  and blots were washed with 0.2x  SSC, 
0.5% SDS at 65~  Low stringency hybridization was performed 
in 0.6 M NaC1, 80 mM Tris-C1, 4 mM EDTA, 0.1% (wt/vol) so- 
dium pyrophosphate, 0.1%  (wt/vol) SDS, 10x  Denhardt's,  100 
mcg/ml denatured herring sperm DNA at 50~  and washed with 
lx  SSC, 0.05% SDS at 50~  Quantitation  of the intensity  of 
band hybridization was determined using a Phosphor-Imager (Mo- 
lecular Dynamics,  Sunnyvale, CA). 
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Statistical Analysis.  The statistical significance of differences be- 
tween means was determined by analysis of variance (ANOVA). 
P <0.05 was considered significant. When ANOVA indicated a 
significant difference, the Newman-Keuls test was used to deter- 
mine which groups were significantly different from each other. 
Results and Discussion 
Analysis of Guinea Pig Eotaxin cDNA.  Using degenerate 
oligonudeotide primers based upon the amino acid sequence 
of guinea pig eotaxin, a 130-bp cDNA was amplified by PCR 
from  guinea  pig lung  single  stranded  cDNA.  This  PCK 
product encoded a peptide identical to eotaxin and was used 
to screen an amplified cDNA library made from the inflamed 
lung  of an  OVA-sensitized  guinea  pig.  From  60 positive 
plaques, six plaques were subsequently purified and their ex- 
cised phagemids had an insert size of"~700-800 bp. Sequence 
analysis  of the longest two inserts revealed  that the regions 
of overlap were identical. The cDNA was 818 bp long with 
an  open reading  frame  that  encoded 96 amino  adds.  The 
predicted protein sequence of the COOH-terminal 73 amino 
acids agreed exactly with the protein sequence of eotaxin iso- 
lated from guinea pig bronchoalveolar fluid (shown under- 
lined in Fig. 1) except for three amino acids that were previ- 
ously ambiguous (shown surrounded by a box in Fig. 1) (17). 
The 5' region of the cDNA encoded a putative hydrophobic 
leader sequence whose cleavage site was predicted to occur 
at  the NH2-terminal  site at which  the active eotaxin pro- 
tein sequence starts (shown with the arrow in Fig.  1) (21). 
This structure strongly suggested that eotaxin was unlikely 
to exist as a precursor protein requiring  additional proteo- 
lytic cleavage for activation.  This type of biochemical pro- 
cessing has been seen with the platelet basic proteins,  members 
of the C-X-C chemokine family (22).  A  Kozak consensus 
sequence for translation  initiation was identified 5' of the AUG 
(23). The 3' untranslated region encoded a mRNA with 59% 
AU nucleotides including two "AUUUA" domains (shown 
with the hatched lines)  that have been reported to decrease 
the mRNA  stability of other cytokine mKNAs  (24). 
The nucleotide sequence showed significant homology to 
other members of the C-C chemokine family, in particular 
to members of the MCP family (25). The full-length cDNA 
was 61, 58, 42, 38, and 52% identical in nucleic acid to human 
MCP-3, MCP-1, MIP-la, R.ANTES, and guinea pig MCP-1, 
respectively. Even greater homology was seen when only the 
region of the cDNA that encoded protein was compared (Table 
1). Comparison of the leader sequence with other sequences 
in the gene data bank revealed that the eotaxin leader sequence 
was homologous only to other leader sequences of the MCP 
family (81 and 74% nucleotide identity and 78 and 70% amino 
acid identity to human MCP-3 and MCP-1, respectively). This 
level of homology suggested that these leader sequences may 
have an additional biological role, perhaps in cellular targeting 
(e.g., localization to a granule sub-compartment). Comparison 
of the homology to other C-C chemokines revealed that the 
nucleotide identity was almost always greater than the amino 
acid identity and similarity (Table  1). Although  the MCPs 
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Figure  1.  Nucleotide  sequence 
and predicted amino add translation 
of full-length guinea pig eotaxin 
eDNA. The underlined  protein se- 
quence corresponds to the sequence 
of mature active eotaxin isolated 
from the bronchoalveolar fluid ex- 
cept  for  the  boxed  amino  acids 
which were previously ambiguous 
(17). The arrow indicates the pre- 
dicted site for signal peptide clea- 
rage. The hatched bars overlie the 
ATTTA sequences that  has been 
reported to decrease mRNA stabil- 
it,/. These sequence  data are araihble 
from EMBL/GenBank/DDBJ under 
accession number U18941. 
attract macrophages, MCP-3 has been reported to cause eo- 
sinophil chemotaxis (10). It remains possible that guinea pig 
eotaxin is the homologue of human MCP-3, but this seems 
unlikely since eotaxin does not display any effect on macro- 
phages in vivo. Furthermore, the proposed murine homologue 
Table  1.  C-C Cheraokine Comparison with Guinea Pig 
Eotaxin * 
Chemokine 
%  Amino acid  % 
Nucleotide 
Identity  Similarity  Identity 
Human MCP-1  56  66  71 
Human MCP-2  54  66  ND 
Human  MCP-3  57  65  73 
Guinea pig MCP-1  45  61  60 
Murine MARC  46  64  64 
Human  MIP-lc~  35  49  50 
Human MIP-1/~  40  56  53 
Human MIP-2c~  23  42  42 
Human MIP-2B  23  38  42 
Human 1-309  31  51  47 
Human  RANTES  28  47  48 
* Comparison over entire 96-amino acid protein and cDNA encoding 
entire transhted protein (bp 69-359). Chemokines in bold have been shown 
to be active on eosinophils. 
of human MCP-3, MARC, is even less homologous to eo- 
taxin than to human MCP-3  (Table 1) (26,  27). 
Eotaxin Gene in the Guinea Pig and Mouse Genome.  Re- 
striction endonuclease treatment of guinea pig DNA (Fig. 2, 
lanes a and b) with analysis by Southern blotting under con- 
ditions of low stringency, revealed a single hybridizing band. 
Mouse genomic DNA cut with EcoRV (Fig. 2, lane c) also 
revealed a single hybridizing band. This data suggests that 
a single gene encodes guinea pig eotaxin and suggests the 
existence of a closely related gene in the mouse. 
Eotaxin mRNA Expression in Different Organs.  Northern 
blot analyses of total RNA isolated from different guinea pig 
tissue samples revealed easily detectable constitutive expres- 
sion  of eotaxin  in  the  lung  (Fig.  3).  The  predominant 
hybridizing band had a size of "0.8 kb. Other hybridizing 
bands were not detectable using poly A-selected RNA (data 
not shown). Lower levels were detectable in the intestines, 
stomach, heart, thymus, spleen, liver, testes, and kidney. In 
these latter tissues, eotaxin mRNA was more easily detected 
on poly A blots (data not shown). The intestine showed some 
variability in expression between two different animals (Fig. 
3). In addition, no RNA was detectable in the brain, bone 
marrow, or skin. Likewise, macrophages isolated and cultured 
from the spleen, a lung epithelial cell line, and a colon ade- 
nocarcinoma  ceU line were  not  found to  express  eotaxin 
mRNA (data not shown). The finding of constitutive eo- 
taxin mRNA in mucosal tissues wherein eosinophils predom- 
inantly reside (lung and intestines) suggests that eotaxin may 
play a role in the normal tissue homing and turnover of eo- 
sinophils. 
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genomic analysis. Guinea pig genomic 
DNA was digested with EcoR1 (lane  a) 
and PvulI (lane b) and mouse genomic 
DNA was digested  with EcoRV  (lane  c). 
After electrophoresis  and transfer  to nylon 
membranes, a guinea pig eotaxin probe 
limited to the coding  region of  the cDNA 
was hybridized and washed under low 
stringency conditions. X-ray  film was ex- 
posed for  2  wk.  Molecular weight 
markers (in kb) are shown to the left for 
lanes a and b and to the right for lane c. 
The Induction of  Eotaxin mRNA  in Allergic Airway Inflam- 
mation.  Since eotaxin  mRNA was found to be expressed 
at relatively high levels in the lung of healthy guinea pigs, 
it was important to determine if this mRNA could account 
for all the protein released after allergen challenge,  or whether 
eotaxin mRNA levels also increased. Therefore guinea pigs 
were sensitized to either aerosolized OVA or exposed to sa- 
line twice at a 7-d interval.  After a third dose of aerosolized 
antigen, the lungs of sensitized, but not saline exposed, guinea 
pigs develop a mucosal and submucosal eosinophil infiltra- 
Figure  3.  Northern analysis of total RNA from various guinea pig 
organs. 10 mcg of  total RNA was resolved  in 1.5% agarose  gels  and trans- 
ferred to nylon membranes. Tissue source is indicated. Splenocytes  were 
treated with 2.5 mcg/ml Con A for 48 h. RNA from intestine and lung 
were  isolated  from two different  animals. Hybridization  and washing were 
performed under conditions of  high stringency  using a guinea pig eotaxin 
probe that was limited to the coding region of the cDNA. X-ray film 
was exposed for 1 wk. 
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Figure 4.  Northern  analysis  of 
poly(A)+ RNA (2 mcg/hne) iso- 
hted from the lungs of  guinea pigs 
challenged 3 h earlier with saline 
(lanes a-f) or OVA (lanes g-l). 
Each lane is RNA from a sepa- 
rate animal. Hybridization was 
performed with a guinea pig eo- 
taxin probe (top)  or a guinea pig 
3-actin probe  (bottom).  X-ray  films 
were exposed for 24 h. 
tion. The inflammation  is most prominent at 17 h and per- 
sists for at least 3 d (13,  18). At various times after antigen 
challenge,  poly A-selected RNA were isolated from repli- 
cate lungs and equal amounts were examined by Northern 
blot analysis for eotaxin mRNA expression. Eotaxin mRNA 
levels increased approximately sixfold (p <0.01) by 3 h com- 
pared with the lungs of saline-treated  guinea pigs (Fig.  4). 
All other time points were not significantly different (Fig. 5). 
The cloning of guinea pig eotaxin cDNA has allowed us 
to make several observations relevant to the biology of eo- 
taxin.  The eotaxin gene is expressed at relatively high levels 
in the lungs of healthy guinea pigs without airway inflam- 
mation. In contrast, the chemotactic activity ascribed to eo- 
taxin has been reported to be undetectable in the bronchoal- 
veolar fluid of non-antigen-challenged guinea pigs (17). Thus, 
eotaxin mRNA is expressed at easily detectable constitutive 
levels in the lung when eotaxin activity is undetectable. This 
presents several alternative possibilities regarding the eotaxin 
protein: (a) it is rapidly degraded; (b) it is expressed at a low 
level which previously was not detectable;  (c) it remains in 
an inaccessible location (e.g., a mast cell granule) and/or is 
biologically inhibited until after antigen challenge; or (d) it 
requires additional biochemical processing for activation or 
some combination of the above.  It is unlikely that  eotaxin 
requires additional processing for activation since the cDNA 
structure predicts that active eotaxin is generated directly after 
removal of the leader sequence. It is interesting that the lungs 
of healthy guinea pigs without eosinophilic  inflammation have 
detectable eosinophils  in the bronchoalveolar fluid at base- 
line (13).  Low levels of eotaxin protein  may regulate basal 
eosinophil  tissue homing. 
After antigen challenge,  eotaxin gene expression in the lung 
is further  increased during  the early part  of the late phase 
response. This change in mRNA parallels  the peak changes 
in eotaxin protein release into the bronchoalveolar fluid which 
also peaks at three hours (17).  Only antigen exposure is as- 
sociated with eosinophilic airway inflammation and bronchial 
hyper-responsiveness (13-15). Thus, upregulation of gene ex- 
pression, and not constitutive gene expression, is associated 
with the pathogenesis of airway disease.  Eotaxin is likely to 
work in parallel with other cytokines generated during the 
late phase response.  For example, IL-5, a cytokine produced 
during the late phase response, can prime eosinophils to re- 
spond to another C-C chemokine,  RANTES, and can pro- 
mote eosinophil  tissue survival  and  activation  (28,  29). 
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Figure 5.  Eotaxin  mR.NA lev- 
ds after  OVA challenge.  OVA sen- 
sitized or saline exposed guinea 
pigs were challenged with aero- 
solized  OVA or saline, respectively, 
and eotaxin mRNA levds in the 
lungs were examined. The inten- 
sity of the band hybridization  was 
detemfined  by a Phosphor-Imager. 
The eotaxin mRNA expression  is 
normalized to guinea pig 13-actin 
mRNA expression  in each sample. 
Data are represented in arbitrary 
units and the results are expressed 
as mean + SEM (n = 5 or 6 ani- 
mals for each group). 
the expression of eotaxin mRNA reveals that in addition to 
the lung, lower levels are seen in a variety of other tissues. 
This suggests a more widespread function for this molecule. 
With the development of immunological reagents to detect 
the eotaxin protein, it will be important to compare protein 
and mRNA expression in these tissues. Finally, this eDNA 
will enable  the identification  of  analogous genes in other species 
and the development of molecular and immunological tools 
to examine the role of this molecule in allergic models and 
human disease. 
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